...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Comparison of Recombinant Trypanosoma cruzi Peptide Mixtures versus Multiepitope Chimeric Proteins as Sensitizing Antigens for Immunodiagnosis
【24h】

Comparison of Recombinant Trypanosoma cruzi Peptide Mixtures versus Multiepitope Chimeric Proteins as Sensitizing Antigens for Immunodiagnosis

机译:重组锥虫锥状蛋白混合物与多表位嵌合蛋白作为免疫诊断敏感抗原的比较

获取原文
           

摘要

The aim of this work was to determine the best strategy to display antigens (Ags) on immunochemical devices to improve test selectivity and sensitivity. We comparatively evaluated five Trypanosoma cruzi antigenic recombinant peptides, chose the three more sensitive ones, built up chimeras bearing these selected Ags, and systematically compared by enzyme-linked immunosorbent assay the performance of the assortments of those peptides with that of the multiepitope constructions bearing all those peptides lineally fused. The better-performing Ags that were compared included peptides homologous to the previously described T. cruzi flagellar repetitive Ag (here named RP1), shed acute-phase Ag (RP2), B13 (RP5), and the chimeric recombinant proteins CP1 and CP2, bearing repetitions of RP1-RP2 and RP1-RP2-RP5, respectively. The diagnostic performances of these Ags were assessed for discrimination efficiency by the formula +OD/cutoff value (where +OD is the mean optical density value of the positive serum samples tested), in comparison with each other either alone, in mixtures, or as peptide-fused chimeras and with total parasite homogenate (TPH). The discrimination efficiency values obtained for CP1 and CP2 were 25% and 52% higher, respectively, than those of their individual-Ag mixtures. CP2 was the only Ag that showed enhanced discrimination efficiency between Chagas' disease-positive and -negative samples, compared with TPH. This study highlights the convenience of performing immunochemical assays using hybrid, single-molecule, chimeric Ags instead of peptide mixtures. CP2 preliminary tests rendered 98.6% sensitivity when evaluated with a 141-Chagas' disease-positive serum sample panel and 99.4% specificity when assessed with a 164-Chagas' disease-negative serum sample panel containing 15 samples from individuals infected with Leishmania spp.
机译:这项工作的目的是确定在免疫化学设备上展示抗原(Ags)的最佳策略,以提高测试的选择性和灵敏度。我们比较评估了五种克鲁姆氏锥虫抗原重组肽,选择了三种更敏感的重组肽,构建了带有这些选定Ag的嵌合体,并通过酶联免疫吸附试验系统地比较了这些肽与带有所有那些线性融合的肽的多表位结构。所比较的表现更好的Ag包括与前述 T同源的肽。 Cruzi 鞭毛重复Ag(此处称为RP1),脱落的急性期Ag(RP2),B13(RP5)以及嵌合重组蛋白CP1和CP2,带有RP1-RP2和RP1-RP2-RP5的重复序列,分别。单独,以混合物形式或以混合物形式比较,通过公式+ OD /临界值(其中+ OD是测试的阳性血清样品的平均光密度值),评估了这些Ag的诊断性能。肽融合的嵌合体,并带有总寄生虫匀浆(TPH)。 CP1和CP2的辨别效率值分别比其单独的Ag混合物高25%和52%。与TPH相比,CP2是唯一显示Chagas疾病阳性和阴性样品之间鉴别效率提高的Ag。这项研究强调了使用杂交,单分子,嵌合Ags而非肽混合物进行免疫化学测定的便利性。当使用141-Chagas's疾病阳性血清样本组进行评估时,CP2初步测试的灵敏度为98.6%,使用164-Chagas's疾病阴性血清样本组进行评估时,CP2初步特异性为99.4%,其中包含15种感染了利什曼原虫的个体 spp。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号